Paul Tudor Jones’s Neos Therapeutics, Inc NEOS Stock Holding History

Paul Tudor Jones’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,000	Closed	-$146K	–	1316
2017 Q2	$146K	Buy	+20,000	New	+$151K	﹤0.01%	929

Other funds holding NEOS

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's NEOS Position: Q3 2017 in Review

Paul Tudor Jones sold out of Neos Therapeutics, Inc (NEOS) in Q3 2017, closing a stake of 20,000 shares — an estimated $146K sold.

Paul Tudor Jones first reported a position in NEOS in Q2 2017 and held it in 1 quarter. The position peaked at $146K in Q2 2017. 63 funds tracked by Wall St. Rank hold NEOS as of Q3 2017.

Paul Tudor Jones reported no remaining Neos Therapeutics, Inc position as of Q3 2017 after selling out during the quarter.
Paul Tudor Jones sold 20,000 Neos Therapeutics, Inc shares in Q3 2017, an estimated $146K.
Paul Tudor Jones first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 1 quarter.
Paul Tudor Jones's Neos Therapeutics, Inc position peaked at $146K in Q2 2017.
63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.